Low utilization of prenatal and pre-implantation genetic diagnosis in Huntington disease - risk discounting in preventive genetics

Clinical Genetics

Volumn 88, Issue 3, 2015, Pages 220-223

  Schulman, J D ^a   Stern, Harvey J ^a  

^a GENETICS AND IVF INSTITUTE   (United States)

Author keywords

Huntington disease; PGD; Prenatal diagnosis; Reproductive options

Indexed keywords

HUNTINGTIN;

ARTICLE; DECISION MAKING; GENETIC COUNSELING; GENETIC RISK; GENETIC SCREENING; HEALTH CARE UTILIZATION; HUMAN; HUNTINGTON CHOREA; MEIOSIS; PRENATAL DIAGNOSIS; PREVALENCE; PRIORITY JOURNAL; FEMALE; GENETICS; HUNTINGTON DISEASE; MALE; PREGNANCY; PROCEDURES; RISK;

FEMALE; GENETIC TESTING; HUMANS; HUNTINGTON DISEASE; MALE; PREGNANCY; PREIMPLANTATION DIAGNOSIS; PRENATAL DIAGNOSIS; RISK;

EID: 84938876807     PISSN: 00099163     EISSN: 13990004     Source Type: Journal    
DOI: 10.1111/cge.12523     Document Type: Article

References (15)

1. Bates G, Harper P, Jones L. Huntington's disease. New York, NY: Oxford University Press, 2002.
2. Klitzman R, Thorne D, Williamson J, Chung W, Marder K. Decision-making about reproductive choices among individuals at-risk for Huntington's disease. J Genet Couns 2007: 16 (3): 347-362.
3. Schulman JD, Black SH, Handyside A, Nance WE. Preimplantation genetic testing for Huntington disease and certain other dominantly inherited disorders. Clin Genet 1996: 49 (2): 57-58.
4. Creighton S, Almqvist EW, MacGregor D et al. Predictive, pre-natal and diagnostic genetic testing for Huntington's disease: the experience in Canada from 1987 to 2000. Clin Genet 2003: 63 (6): 462-475.
5. Braude PR, De Wert GM, Evers-Kiebooms G, Pettigrew RA, Geraedts JP. Non-disclosure preimplantation genetic diagnosis for Huntington's disease: practical and ethical dilemmas. Prenat Diagn 1998: 18 (13): 1422-1426.
6. de Die-Smulders CE, de Wert GM, Liebaers I, Tibben A, Evers-Kiebooms G. Reproductive options for prospective parents in families with Huntington's disease: clinical, psychological and ethical reflections. Hum Reprod Update 2013: 19 (3): 304-315.
7. Hershberger PE, Pierce PF. Conceptualizing couples' decision making in PGD: emerging cognitive, emotional, and moral dimensions. Patient Educ Couns 2010: 81 (1): 53-62.
8. Pringsheim T, Wiltshire K, Day L, Dykeman J, Steeves T, Jette N. The incidence and prevalence of Huntington's disease: a systematic review and meta-analysis. Mov Disord 2012: 27 (9): 1083-1091.
9. Stern HJ, Harton GL, Sisson ME et al. Non-disclosing preimplantation genetic diagnosis for Huntington disease. Prenat Diagn 2002: 22 (6): 503-507.
10. Harper JC, Wilton L, Traeger-Synodinos J et al. The ESHRE PGD Consortium: 10 years of data collection. Hum Reprod Update 2012: 18 (3): 234-247.
11. Divino V, Dekoven M, Warner JH et al. The direct medical costs of Huntington's disease by stage. A retrospective commercial and Medicaid claims data analysis. J Med Econ 2013: 16 (8): 1043-1050.
12. Chung DC, Rustgi AK. The hereditary nonpolyposis colorectal cancer syndrome: genetics and clinical implications. Ann Intern Med 2003: 138 (7): 560-570.
13. Sharaf RN, Myer P, Stave CD, Diamond LC, Ladabaum U. Uptake of genetic testing by relatives of lynch syndrome probands: a systematic review. Clin Gastroenterol Hepatol 2013: 11 (9): 1093-1100.
14. Julian-Reynier C, Sobol H, Sevilla C, Nogues C, Bourret P. Uptake of hereditary breast/ovarian cancer genetic testing in a French national sample of BRCA1 families. The French Cancer Genetic Network. Psychooncology 2000: 9 (6): 504-510.
15. Landsbergen K, Verhaak C, Kraaimaat F, Hoogerbrugge N. Genetic uptake in BRCA-mutation families is related to emotional and behavioral communication characteristics of index patients. Fam Cancer 2005: 4 (2): 115-119.